Design and development of polymeric liquid dressing containing quercetin for accelerated wound healing in effective management of pressure ulcers

IF 4.5 Q2 PHARMACOLOGY & PHARMACY
Ayesha Syed, Preeti Karwa, Sohal Mallick, Adarsh Manjunath Hedge, C. A. Madan Babu
{"title":"Design and development of polymeric liquid dressing containing quercetin for accelerated wound healing in effective management of pressure ulcers","authors":"Ayesha Syed,&nbsp;Preeti Karwa,&nbsp;Sohal Mallick,&nbsp;Adarsh Manjunath Hedge,&nbsp;C. A. Madan Babu","doi":"10.1186/s43094-026-01003-9","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>This study aimed to develop and optimize a quercetin-loaded film-forming spray as a liquid wound dressing to overcome the limitations of conventional pressure ulcer therapies, particularly poor skin penetration and insufficient drug retention. The formulation was designed to enhance localized quercetin delivery, improve residence time at the wound site, and promote accelerated wound healing while ensuring skin compatibility.</p><h3>Methods</h3><p>The film-forming spray was formulated and optimized using a Taguchi orthogonal array design. The optimized formulation comprised Eudragit RSPO (1%), propylene glycol (1%), and an ethanol:acetone solvent system (7:3). Comprehensive evaluation of the formulation included physicochemical characterization, ex vivo permeation studies using rat skin, skin irritation assessment, and in vivo therapeutic evaluation in a pressure ulcer model. Wound-healing efficacy was assessed through measurement of wound closure, tensile strength, hydroxyproline content, and detailed histopathological analysis.</p><h3>Results</h3><p>The optimized formulation demonstrated ideal film-forming properties with 98 ± 0.45 s drying time and excellent spray characteristics. It showed 3.89-fold higher permeation and 16-fold greater skin deposition compared to pure quercetin. The formulation was non-irritating and showed accelerated wound healing to 20 days versus 24 days for standard marketed formulation. Treated wounds exhibited significantly higher tensile strength (46,479 ± 3.8 N/m<sup>2</sup>) and hydroxyproline content (0.4752 mg), confirming enhanced collagen deposition and tissue regeneration.</p><h3>Conclusion</h3><p>The developed quercetin-loaded film-forming spray represents a promising approach in topical wound therapy, demonstrating superior drug delivery, accelerated healing, and enhanced tissue quality, making it a promising therapeutic alternative for pressure ulcer management.</p></div>","PeriodicalId":577,"journal":{"name":"Future Journal of Pharmaceutical Sciences","volume":"12 1","pages":""},"PeriodicalIF":4.5000,"publicationDate":"2026-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1186/s43094-026-01003-9.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Journal of Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://link.springer.com/article/10.1186/s43094-026-01003-9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose

This study aimed to develop and optimize a quercetin-loaded film-forming spray as a liquid wound dressing to overcome the limitations of conventional pressure ulcer therapies, particularly poor skin penetration and insufficient drug retention. The formulation was designed to enhance localized quercetin delivery, improve residence time at the wound site, and promote accelerated wound healing while ensuring skin compatibility.

Methods

The film-forming spray was formulated and optimized using a Taguchi orthogonal array design. The optimized formulation comprised Eudragit RSPO (1%), propylene glycol (1%), and an ethanol:acetone solvent system (7:3). Comprehensive evaluation of the formulation included physicochemical characterization, ex vivo permeation studies using rat skin, skin irritation assessment, and in vivo therapeutic evaluation in a pressure ulcer model. Wound-healing efficacy was assessed through measurement of wound closure, tensile strength, hydroxyproline content, and detailed histopathological analysis.

Results

The optimized formulation demonstrated ideal film-forming properties with 98 ± 0.45 s drying time and excellent spray characteristics. It showed 3.89-fold higher permeation and 16-fold greater skin deposition compared to pure quercetin. The formulation was non-irritating and showed accelerated wound healing to 20 days versus 24 days for standard marketed formulation. Treated wounds exhibited significantly higher tensile strength (46,479 ± 3.8 N/m2) and hydroxyproline content (0.4752 mg), confirming enhanced collagen deposition and tissue regeneration.

Conclusion

The developed quercetin-loaded film-forming spray represents a promising approach in topical wound therapy, demonstrating superior drug delivery, accelerated healing, and enhanced tissue quality, making it a promising therapeutic alternative for pressure ulcer management.

设计和开发含有槲皮素的聚合物液体敷料,用于加速伤口愈合,有效地管理压疮
本研究旨在开发和优化槲皮素成膜喷雾剂作为液体伤口敷料,以克服传统压疮治疗方法的局限性,特别是皮肤渗透性差和药物潴留不足。该配方旨在增强槲皮素的局部递送,改善在伤口部位的停留时间,促进伤口加速愈合,同时确保皮肤相容性。方法采用田口正交设计对成膜喷雾剂进行配方优化。优化后的配方由乌龙茶RSPO(1%)、丙二醇(1%)和乙醇:丙酮(7:3)溶剂体系组成。该制剂的综合评价包括理化特性、大鼠皮肤体外渗透研究、皮肤刺激评估和压疮模型体内治疗评估。通过测量创面闭合、拉伸强度、羟脯氨酸含量和详细的组织病理学分析来评估创面愈合效果。结果优化后的配方具有理想的成膜性能,干燥时间为98±0.45 s,喷雾性能优良。与纯槲皮素相比,其渗透性高3.89倍,皮肤沉积量高16倍。该配方无刺激性,与标准上市配方的24天相比,伤口愈合速度加快了20天。处理后的伤口抗拉强度(46,479±3.8 N/m2)和羟脯氨酸含量(0.4752 mg)显著提高,证实胶原沉积和组织再生增强。结论槲皮素负载成膜喷雾剂是一种很有前途的伤口局部治疗方法,具有良好的药物传递性,加速愈合,提高组织质量,使其成为压疮治疗的一种有前景的治疗选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
44
审稿时长
23 weeks
期刊介绍: Future Journal of Pharmaceutical Sciences (FJPS) is the official journal of the Future University in Egypt. It is a peer-reviewed, open access journal which publishes original research articles, review articles and case studies on all aspects of pharmaceutical sciences and technologies, pharmacy practice and related clinical aspects, and pharmacy education. The journal publishes articles covering developments in drug absorption and metabolism, pharmacokinetics and dynamics, drug delivery systems, drug targeting and nano-technology. It also covers development of new systems, methods and techniques in pharmacy education and practice. The scope of the journal also extends to cover advancements in toxicology, cell and molecular biology, biomedical research, clinical and pharmaceutical microbiology, pharmaceutical biotechnology, medicinal chemistry, phytochemistry and nutraceuticals.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书